Bio-Rad Launches Assay Kit for Zika, Dengue, and Chikungunya Detection
The RT-PCR kit can simultaneously screen samples for Zika, dengue, and chikungunya arbovirus RNAs.
On June 6, 2017, Bio-Rad launched a RT-PCR kit that allows researchers to simultaneously screen samples for Zika, dengue, and chikungunya arbovirus RNAs. The assay comes with the controls researchers need to internally validate the results. According to the company, this assay is approved for research use only and is currently available only outside the United States.
The ZDC Multiplex RT-PCR Assay (Research Use Only) is a one-step reverse-transcription, real-time PCR assay for the simultaneous detection and quantification of Zika, dengue, and chikungunya arbovirus RNAs from a range of specimen types.
“Our assay provides researchers an effective and reliable tool for the concurrent detection of Zika, dengue, and chikungunya RNAs in a single reaction tube,” said Luca Boveri, PhD, Bio-Rad global product manager, Gene Expression, in a statement. “Researchers can now rely on a wet-lab validated tool whose key components have been manufactured in GMP-approved facilities and extensively tested to generate consistent results.”
Source: Bio-Rad
EXO Biologics and ExoXpert Reach Two Critical Milestones that Advance Exosomes
December 3rd 2024EXO Biologics and its subsidiary, ExoXpert, have received GMP certification of a European exosomes manufacturing facility and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
